Recent recorded grades — Spring 2024: 4.00 GPA, 100.0% A/AB (n=6 letter grades); Spring 2025: 3.88 GPA, 93.8% A/AB (n=16 letter grades); Spring 2026: 4.00 GPA, 100.0% A/AB (n=12 letter grades). Includes jointly taught sections.
Spring 2027
Business Tools for Pharmaceutical Scientists
Business Tools for Pharmaceutical Scientists explores business aspects of pharmaceutical product development and post-approval product maturation.
offering recorded3 credits
Summary
1 / 3
Recent recorded grades — Spring 2024: 4.00 GPA, 100.0% A/AB (n=6 letter grades); Spring 2025: 3.88 GPA, 93.8% A/AB (n=16 letter grades); Spring 2026: 4.00 GPA, 100.0% A/AB (n=12 letter grades).
What you’ll be able to do
Identify the essential features of a well-constructed life cycle management plan for different types of pharmaceutical products (small molecules, biologics, in vitro diagnostics, and medical devices).
Analyze the elements of business development for a novel therapeutic and contrast the differences between a startup effort vs. one from an established company.
Describe the key business considerations involved in pharmaceutical product development.
Justify strategies for mitigating scientific and business risks.
Predict and evaluate how different market forces and business decisions impact supply chains.
Explain the role of intellectual property during pharmaceutical product development and post-approval lifecycle.
Source: UW Guide
Grade history
↗ average GPA
4242 letter grades
A92.9%92.9%
AB4.8%4.8%
B2.4%2.4%
BC0.0%0.0%
C0.0%0.0%
D0.0%0.0%
F0.0%0.0%
All recorded terms · compare terms & instructors
Prerequisites
Course mapDeclared in Pharmaceutical Sciences MS
- Declared in Pharmaceutical Sciences MS
This is a best-effort interpretation; check the catalog requirements above.
Prerequisite text tree
- Declared in Pharmaceutical Sciences MS
Professors
Spring 2027Recent recorded grades — Spring 2024: 4.00 GPA, 100.0% A/AB (n=6 letter grades); Spring 2025: 3.88 GPA, 93.8% A/AB (n=16 letter grades); Spring 2026: 4.00 GPA, 100.0% A/AB (n=12 letter grades). Includes jointly taught sections.
Historical instructors & teaching patterns
STEPHAN LOOSE is recorded teaching in Spring 2024, Spring 2025, Spring 2026. Recorded history may be incomplete and does not establish a future schedule.
TERRANCE OCHELTREE is recorded teaching in Spring 2023, Spring 2024, Spring 2025, Spring 2026. Recorded history may be incomplete and does not establish a future schedule.
Recorded history may be incomplete and does not establish a future schedule.
Calendar & sections
Spring 2027Schedule loads here as you scroll.
| Section | Mode | Enrolled / capacity | Waitlist |
|---|---|---|---|
| LEC 001 | Online Only | 0 / 30 | 0 |
| LEC 002 | Online (some classroom) | 0 / 30 | 0 |
Times are Central. Select a meeting for details; export includes recorded dates for the selected sections. Enrollment reflects scan time.
Meeting source records
Student experience
the class
Recent recorded grades — Spring 2024: 4.00 GPA, 100.0% A/AB (n=6 letter grades); Spring 2025: 3.88 GPA, 93.8% A/AB (n=16 letter grades); Spring 2026: 4.00 GPA, 100.0% A/AB (n=12 letter grades).
difficulty & workload
No workload feedback recorded.
Topics
- Startup financing, risk management, intellectual property, supply chain management, and strategic decision-making.
- Pharmaceutical product types including small molecules, biologics, in vitro diagnostics, and medical devices.
- Business development comparisons between startup efforts and established companies.
Skills
- Startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making.
- Constructing life cycle management plans for small molecules, biologics, in vitro diagnostics, and medical devices.
- Justifying strategies for mitigating scientific and business risks.
- Explaining the role of intellectual property during product development and post-approval lifecycle.
Grades
Latest available · Spring 2026— not enough history to project Spring 2027.
average GPA
A / AB grades
letter grades
Instructor
Grade distribution · % of letter grades
A100.0%100.0%
AB0.0%0.0%
B0.0%0.0%
BC0.0%0.0%
C0.0%0.0%
D0.0%0.0%
F0.0%0.0%
Grades over time
Through Spring 2026
More grade details Grade mix, volume & source data
Not enough comparable courses for Spring 2027 in UW–Madison.
Sources & history
UW–Madison
Catalog & offerings
Descriptions, prerequisites, and recorded course offerings.
Catalog observation history
Observations at scan time; dates do not imply when a catalog change took effect.
Selected offering source records
Business Tools for Pharmaceutical Scientists
Recorded 2026-10-14Raw records
[
{
"run_id": "20261014T203208-0851c9a1",
"semester": "1274",
"observed_at": "2026-10-14 17:50:09.728220+00:00",
"offering_id": "1274:718:026404",
"course_id": "PHMSCI 754",
"course_uid": "course_37897e8c1cc993a9a0ae5230",
"term_id": "1274",
"source_course_id": "026404",
"source_subject_id": "718",
"title": "Business Tools for Pharmaceutical Scientists",
"credits_min": 3,
"credits_max": 3,
"typically_offered": "Not Applicable"
}
]Rate My Professors
Student reviews
Original comments behind the course and instructor summaries.
Read original reviews
No records available.
Madgrades
Grade history
Recorded grade distributions by term, section, and instructor.
Explore recorded gradesDataset & model
View the dataset on Hugging Face Recorded 2026-10-14
Model outputs & technical records
Qwen/Qwen3.8-27B
LLM outputs across runs
Full model traces
Recorded model configuration, reasoning, and tool conversations.
Model & dataset provenance
{
"model": "Qwen/Qwen3.8-27B",
"model_revision": "1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0",
"task_version": "17",
"output_id": "c73ac2b6ca889e5fc3e9351ecb3635fd053d44e085d97903d16fe813bfa19912",
"requirements_status": "valid",
"dataset_revision": "fc1811fa52e581ea57a35c0cf3343f8740a8ffbf",
"observed_at": "2026-10-14 17:50:09.728220+00:00"
}